Myeloid cells in hepatocellular carcinoma
作者： Shanshan Wan , Ning Kuo , Ilona Kryczek , Weiping Zou , Theodore H. Welling
DOI: 10.1002/HEP.27867
关键词:
摘要: Hepatocellular carcinoma (HCC) is highly associated with inflammation. Myeloid cells, including tumor-associated macrophages and myeloid-derived suppressor are abundant in the HCC microenvironment often poor prognosis. cells play a vital role supporting tumor initiation, progression, angiogenesis, metastasis, therapeutic resistance. Here, we summarize our current knowledge about myeloid focus on their immune-suppressive activities tumor-promoting functions, as well relevance to potential new therapies HCC.
core.ac.uk
sci-hub.se 参考文章(63)
Martin Roderfeld, Timo Rath, Frank Lammert, Christian Dierkes, Jürgen Graf, Elke Roeb, Innovative immunohistochemistry identifies MMP-9 expressing macrophages at the invasive front of murine HCC. World Journal of Hepatology. ,vol. 2, pp. 175- 179 ,(2010) , 10.4254/WJH.V2.I5.175
Erica M. Hanson, Virginia K. Clements, Pratima Sinha, Dan Ilkovitch, Suzanne Ostrand-Rosenberg, Myeloid-Derived Suppressor Cells Down-Regulate L-Selectin Expression on CD4+ and CD8+ T Cells Journal of Immunology. ,vol. 183, pp. 937- 944 ,(2009) , 10.4049/JIMMUNOL.0804253
Qiyi Zhao, Dong-Ming Kuang, Yan Wu, Xiao Xiao, Xue-Feng Li, Tuan-Jie Li, Limin Zheng, Activated CD69+ T Cells Foster Immune Privilege by Regulating IDO Expression in Tumor-Associated Macrophages Journal of Immunology. ,vol. 188, pp. 1117- 1124 ,(2012) , 10.4049/JIMMUNOL.1100164
Peng Shen, Aijuan Wang, Mengye He, Qingqing Wang, Shusen Zheng, Increased circulating Lin(-/low) CD33(+) HLA-DR(-) myeloid-derived suppressor cells in hepatocellular carcinoma patients. Hepatology Research. ,vol. 44, pp. 639- 650 ,(2014) , 10.1111/HEPR.12167
Yoshinori Narita, Daiko Wakita, Takayuk Ohkur, Kenji Chamoto, Takashi Nishimura, Potential differentiation of tumor bearing mouse CD11b+Gr-1+ immature myeloid cells into both suppressor macrophages and immunostimulatory dendritic cells. Biomedical Research-tokyo. ,vol. 30, pp. 7- 15 ,(2009) , 10.2220/BIOMEDRES.30.7
Roy Noy, Jeffrey W. Pollard, Tumor-associated macrophages: from mechanisms to therapy. Immunity. ,vol. 41, pp. 49- 61 ,(2014) , 10.1016/J.IMMUNI.2014.06.010
Esther F. A. Brandon, Irma Meijerman, Joyce S. Klijn, Dineke den Arend, Rolf W. Sparidans, Louis L??pez L??zaro, Jos H. Beijnen, Jan H. M. Schellens, In-vitro cytotoxicity of ET-743 (Trabectedin, Yondelis), a marine anti-cancer drug, in the Hep G2 cell line: influence of cytochrome P450 and phase II inhibition, and cytochrome P450 induction. Anti-Cancer Drugs. ,vol. 16, pp. 935- 943 ,(2005) , 10.1097/01.CAD.0000180121.16407.38
Bastian Hoechst, Torsten Voigtlaender, Lars Ormandy, Jaba Gamrekelashvili, Fei Zhao, Heiner Wedemeyer, Frank Lehner, Michael P. Manns, Tim F. Greten, Firouzeh Korangy, Myeloid Derived Suppressor Cells Inhibit Natural Killer Cells in Patients with Hepatocellular Carcinoma via the NKp30 Receptor Hepatology. ,vol. 50, pp. 799- 807 ,(2009) , 10.1002/HEP.23054
Yoshito Wada, Osamu Nakashima, Rumiko Kutami, Osamu Yamamoto, Masamichi Kojiro, Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration. Hepatology. ,vol. 27, pp. 407- 414 ,(1998) , 10.1002/HEP.510270214
Alberto Mantovani, Antonio Sica, Paola Allavena, Cecilia Garlanda, Massimo Locati, Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation. Human Immunology. ,vol. 70, pp. 325- 330 ,(2009) , 10.1016/J.HUMIMM.2009.02.008